Transurethral Seminal Vesiculoscopy (TUSV) Carplate on my Ferrari F430

Visiting new hospital in Shenzhen at Qianhai

Pseudo robotic arm

Rapid-Fire #Debate: Patient with high-risk #NMIBC - Is BCG still the best option in 2025? Yes, BCG is still king. Presentation by Gianluca Giannarini. #EAU25 written coverage by Zach Klaassen Georgia Cancer Center on UroToday > bit.ly/4hxtUqe European Association of Urology (EAU)

Trial CI Bryant_Lab delighted to read out #TRANSLATE_Trial results during #GameChanger session European Association of Urology (EAU) #EAU25 Thank you to all our investigators, recruiting sites, funders National Institute for Health and Care Research and, most importantly, our 1126 pts! thelancet.com/journals/lanon… Trial visual abstract below ⬇️

My honor to speak in 10th UCI Advanced International Men’s Helath Course on 25th Jan 2026 on Transurethral Seminal Vesiculoscopy #TUSV

My Ghibli style profile pic

Union Hospital 30th anniversary

Enbloc BT-ESD Radical endoscopic resection of bladder tumor with >95% chance of DM inclusion in the specimen

Bladder cancer care is evolving fast! 🧬Molecular subtyping = better personalization 🩸Liquid biopsy = non-invasive precision 💉Immunotherapy & ADCs = reshaping 1L & 2L treatment A future of more tailored, less toxic care is coming, hopefully! The BMJ OncoAlert

congratulations

🚀 A novel PSMA-targeted Tri-Specific Killer Engager (TriKE) boosts NK cell cytotoxicity in prostate cancer! 🧬 Targets PSMA ⚔️ Activates NK cells via CD16 💥 Delivers IL-15 for NK survival & function 🔥 Overcomes "cold" TME & tumor antigen escape 🤝 Potential synergy with ICIs

Mini me

Common sense is not common

New pub alert 🚨 The bladder microbiome may influence intravesical chemotherapy response in bladder cancer. 🦠💊 🧪 we tested uropathogenic E. coli (UPEC) and gemcitabine Results> • Ecoli can enter tumor cells (of course) • Inactivate gemcitabine → converting it to an

HoLEP 175gm prostate

congrat!